485 related articles for article (PubMed ID: 8238545)
1. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Barrett RJ; Droppleman DA
Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
[TBL] [Abstract][Full Text] [Related]
2. The endothelium of the rat renal artery plays an obligatory role in A2 adenosine receptor-mediated relaxation induced by 5'-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine.
Martin PL; Potts AA
J Pharmacol Exp Ther; 1994 Sep; 270(3):893-9. PubMed ID: 7932201
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension.
Qiu C; Engels K; Baylis C
Am J Physiol; 1994 May; 266(5 Pt 2):R1470-6. PubMed ID: 8203622
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II: nitric oxide interaction and the distribution of blood flow.
Sigmon DH; Beierwaltes WH
Am J Physiol; 1993 Dec; 265(6 Pt 2):R1276-83. PubMed ID: 8285267
[TBL] [Abstract][Full Text] [Related]
6. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
7. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
8. Interactions between nitric oxide and angiotensin II on renal cortical and papillary blood flow.
Madrid MI; García-Salom M; Tornel J; de Gasparo M; Fenoy FJ
Hypertension; 1997 Nov; 30(5):1175-82. PubMed ID: 9369273
[TBL] [Abstract][Full Text] [Related]
9. Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat.
Nossaman BD; Feng CJ; Kaye AD; Kadowitz PJ
Am J Physiol; 1995 Feb; 268(2 Pt 1):L302-8. PubMed ID: 7864150
[TBL] [Abstract][Full Text] [Related]
10. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V
Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065
[TBL] [Abstract][Full Text] [Related]
11. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
Maeso R; Navarro-Cid J; Muñoz-García R; Rodrigo E; Ruilope LM; Lahera V; Cachofeiro V
Hypertension; 1996 Dec; 28(6):967-72. PubMed ID: 8952584
[TBL] [Abstract][Full Text] [Related]
12. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds.
Osei SY; Ahima RS; Minkes RK; Weaver JP; Khosla MC; Kadowitz PJ
Eur J Pharmacol; 1993 Mar; 234(1):35-42. PubMed ID: 7682513
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
Valentin JP; Bessac AM; Maffre M; John GW
Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
[TBL] [Abstract][Full Text] [Related]
14. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II.
Baylis C; Engels K; Samsell L; Harton P
Am J Physiol; 1993 Jan; 264(1 Pt 2):F74-8. PubMed ID: 8430832
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II-induced renal responses in anesthetized rabbits: effects of N omega-nitro-L-arginine methyl ester and losartan.
Adachi Y; Hashimoto K; Hisa H; Yoshida M; Suzuki-Kusaba M; Satoh S
Eur J Pharmacol; 1996 Jul; 308(2):165-71. PubMed ID: 8840128
[TBL] [Abstract][Full Text] [Related]
16. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles.
Ohishi K; Carmines PK; Inscho EW; Navar LG
Am J Physiol; 1992 Nov; 263(5 Pt 2):F900-6. PubMed ID: 1332506
[TBL] [Abstract][Full Text] [Related]
17. Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration.
Nafrialdi N; Jover B; Mimran A
J Cardiovasc Pharmacol; 1994 May; 23(5):765-71. PubMed ID: 7521459
[TBL] [Abstract][Full Text] [Related]
18. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin II in hemodynamic responses to dynamic exercise in miniswine.
Stebbins CL; Symons JD
J Appl Physiol (1985); 1995 Jan; 78(1):185-90. PubMed ID: 7713810
[TBL] [Abstract][Full Text] [Related]
20. Role of NO and COX pathways in mediation of adenosine A1 receptor-induced renal vasoconstriction.
Walkowska A; Dobrowolski L; Kompanowska-Jezierska E; Sadowski J
Exp Biol Med (Maywood); 2007 May; 232(5):690-4. PubMed ID: 17463166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]